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Abstract: Amplitude-integrated electroencephalogram (aEEG) is a readily available and practical tool for
the assessment of time-compressed electroencephalogram (EEG) trend at the bedside. Its interpretation
and its learnability are considerably easier compared to those of conventional EEG. For those reasons,
aEEG is now a daily part of clinical surveillance for continuous brain function monitoring of critically ill
patients in some neonatal intensive care units (NICU). Another reason for the growing interest in this
tool for electrophysiological measures is explained by the fact that continuous brain function monitoring
early after birth may represent the possibility to early assess the neurological integrity of the newborn and
thus, to early select patient needing neuroprotective intervention and to predict outcome. This has been
largely demonstrated for the asphyxiated full-term, but not in similar extent for the preterm newborn,
whose aEEG background pattern differs sensibly from that of the full-term newborn. Early detection
of newborns at particular risk for cerebral injury and further neurodevelopmental disability (ND) still
represents one of the major challenges of preterm medical care. At bedside, the aEEG assessment focuses
theoretically on the amplitude variations of the raw EEG, and practically on the recognition of the
dominant background pattern of activity, the presence and maturational aspect of cycling activity and the
presence of seizure activity. Pathological changes in the aEGG tracing are characterized by a depression
of the background pattern, a lack or an inadequate maturation of the cycling activity, and the occurrence
of seizures. Today, clinicians increasingly use aEEG also in preterms, an ever-growing NICU patient
population at high risk for cerebral injury and thus ND. Recent studies showed that changes in the aEEG
pattern are associated with poor outcome in the preterm newborns. However, it still remains to be
elucidated how and under which conditions aEEG tracing evolves during the very early life period in this
patient population, especially in unstable health condition. Although the subject of the present work is
the aEEG, this thesis firstly discusses recent data on the outcome of preterm infants born in Switzerland,
in order to bring this population of patients into the reader’s focus and to define the consequences of
prematurity. Thanks to a solid collaboration between perinatal and follow up centres and an established
follow up program in Switzerland we are now able to better analyse representative data concerning the
development of preterm newborns on a national level. Swiss outcome data of 2 years old former extremely
preterms show that, although more than a third of infants still suffer from moderate or severe ND, the
rate of survival without major neurologic sequelae has increased significantly over the last decade, while
the mortality rate decreased. Interestingly, while neonatal mortality is predominantly dependent on
gestational age, birth weight and antenatal corticosteroids, the outcome at two years of age in children
surviving the neonatal period is best predicted by neonatal morbidities like, among others, major brain
lesions. There is concern whether prematurity and ND affect late outcome. We provided data on quality
of life of former extremely low birth weight preterms at young adulthood born in Switzerland in the
early 1980s, showing overall satisfactory results though some observable differences between preterms
and community norms. This thesis delineates and discusses the application, the clinical utility of the
aEEG as well as its predictive value in terms of short- and long-term outcome of preterm newborns. First,
technical aspects concerning the methodology and the assessment of the aEEG tracing are explained, with
special focus on the potential aEEG signal confounders that interfere with a correct tracing evaluation.
We added information in particular on the influence of sedatives on the course of the aEEG tracing in
newborns. Second, the prediction of neonatal and further outcome of the preterm newborn is detailed
discussed. Early recognition of preterm patients at higher risk for adverse outcome is important in
order to better setup neonatal care and post-discharge intervention. Neuroprotective studies in preterm
infants are being conducted to improve long-term outcome and robust biomarkers would help to guide
such interventional strategies and to help parental counselling. This thesis demonstrates that changes
in the aEEG background activity can predict short-term outcome in preterm infants. The maturational
aspect of the early aEEG background tracing in preterm infants relates to structural brain maturation at
term equivalent age as assessed qualitatively by magnetic resonance imaging. A delay in the maturation
of cyclic aEEG activity in the preterm newborn may be a sign of the development of a major brain
lesion. A review of the results of other studies on the predictive value of aEEG for outcome at early
childhood is finally included. In conclusion the results of this thesis indicate that aEEG is a valuable
neurophysiologic diagnostic tool for early continuous bedside monitoring of brain function and that its
background activity can predict short-term outcome in preterm infants. The assessment of the tracing
evolution and the detection of sensitive markers of brain lesion during aEEG monitoring could prove
critical for implication of therapeutic assistance. Several clinical conditions and artefactual features may
however, alter the aEEG tracing and interfere with its interpretation and consequently the prognostic
evaluation. Training in the aEEG assessment and knowledge of the potential aEEG signal confounders is
therefore needed in order to better further implement this promising neuromonitoring tool in the NICU.
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1. Summary 
Amplitude-integrated electroencephalogram (aEEG) is a readily available and 
practical tool for the assessment of time-compressed electroencephalogram (EEG) 
trend at the bedside. Its interpretation and learnability are considerably easier 
compared to those of conventional EEG. For those reasons, aEEG is now used 
routinely to continuously monitor brain function in critically ill infants in some neonatal 
intensive care units (NICU). Another reason for the growing interest in this 
electrophysiological measuring tool is that continuous brain function monitoring 
shortly after birth may represent the possibility to early assess the neurological 
integrity of the newborn infant and thus, to select patients benefitting from 
neuroprotective intervention and ultimately to predict outcome. This has been 
extensively demonstrated for full-term infants with neonatal encephalopathy following 
perinatal asphyxia, but not to a similar extent for preterm infants, whose aEEG 
background pattern differs sensibly from that of the full-term infant. Early detection of 
newborn infants at particular risk for cerebral injury and further neurodevelopmental 
disability (ND) still represents one of the major challenges of preterm medical care. 
At bedside, aEEG assessment focuses theoretically on the amplitude variations of 
the underlying raw EEG, and practically on the recognition of the dominant 
background pattern of activity, the presence and maturational aspect of cycling 
activity, and the presence of seizure activity. Pathological changes in the aEGG 
tracing are characterized by a depression of the background pattern, a lack or an 
inadequate maturation of the cycling activity, and the occurrence of seizures. Today, 
clinicians increasingly use aEEG also in preterm infants, an ever-growing NICU 
patient population at high risk for cerebral injury and thus ND. Recent studies have 
shown that changes in the aEEG pattern may be associated with poor outcome in the 
preterm infants. However, it still remains to be elucidated how and under which 
conditions aEEG tracing evolves during the very early life period in this patient 
population, especially in unstable health condition. 
In the first section, this thesis discusses recent data on the outcome of preterm 
infants born in Switzerland, in order to bring this population of patients into the 
reader’s focus and to define the consequences of prematurity. Thanks to a strong 
collaboration between perinatal and follow up centres and an established follow up 
program in Switzerland, we are now able to better analyse representative data 
concerning the development of preterm infants on a national level. Swiss outcome 
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data of 2 years old former extremely preterm infants show that, although more than a 
third of infants still suffer from moderate or severe ND, the rate of survival without 
major neurologic sequelae has significantly increased over the last decade, while the 
mortality rate has decreased. Interestingly, while neonatal mortality is predominantly 
dependent on gestational age, birth weight and antenatal corticosteroids, the 
outcome at two years of age in children surviving the neonatal period is best 
predicted by neonatal morbidities such as major brain lesions, bronchopulmonary 
dysplasia, and retinopathy of prematurity. There is concern whether prematurity and 
ND may affect later outcome in adulthood. We provided data on quality of life of 
former extremely low birth weight preterm infants, born in Switzerland in the early 
1980s, at young adulthood, showing overall satisfactory results despite some 
observable differences between preterms and community norms. 
The focus of the second and main section of this thesis is the application of aEEG in 
preterm born infants. This thesis outlines and discusses the technique, the clinical 
utility of the aEEG and, most importantly, its predictive value in terms of short- and 
long-term outcome of preterm infants. First, technical aspects concerning the 
methodology and the assessment of the aEEG tracing are explained, with special 
focus on the potential aEEG signal confounders that interfere with a correct tracing 
evaluation. In particular, we provided data on the influence of sedatives of the aEEG 
tracing in newborn infants. Second, the prediction of neonatal and early childhood 
outcome of preterm infants is discussed in detail. Early recognition of preterm 
patients at particular risk for adverse outcome is important in order to tailor neonatal 
care and post-discharge intervention. Neuroprotective studies in preterm infants are 
being conducted to improve long-term outcome and robust biomarkers will help to 
guide such interventional strategies and to help parental counselling. This thesis 
demonstrates that changes in the aEEG background activity can predict short-term 
outcome in preterm infants. The maturational aspect of the early aEEG background 
tracing in preterm infants relates to structural brain maturation at term equivalent age 
as assessed qualitatively by magnetic resonance imaging. Additionally, a delay in the 
maturation of cyclic aEEG activity in the preterm newborn infant may be a sign of the 
development of a major brain lesion. This section ends with a review of the results of 
studies on the predictive value of aEEG for outcome at early childhood. 
In conclusion the results of this thesis indicate that aEEG is a valuable 
neurophysiologic diagnostic tool for early continuous bedside monitoring of brain 
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function and aEEG background activity can predict short-term outcome in preterm 
infants. The assessment of the tracing evolution and the detection of sensitive 
markers of brain lesion during aEEG monitoring could prove critical for the selection 
and instruction of patients eligible for early neuroprotective therapies. Several clinical 
conditions and artefactual features may, however, alter the aEEG tracing and thus 
interfere with the interpretation and prognostic value of the aEEG. Training in the 
aEEG assessment and knowledge of the potential aEEG signal confounders is 
therefore needed to further improve the implementation of this promising 
neuromonitoring tool in the NICU. 
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2. List of abbreviations 
aEEG:   Amplitude-integrated EEG 
cMRI   Cranial magnetic resonance imaging 
cPVL   Cystic periventricular leukomalacia 
cUS   Cranial ultrasound scan  
EEG:   Electroencephalogram 
GA:    Gestational age 
IVH:   Intraventricular haemorrhage 
ND:   Neurodevelopmental disability 
NICU   Neonatal intensive care unit 
NPV   Negative predictive value 
PMA:   Postmenstrual age* 
PPV   Positive predictive value 
PVHI   Periventricular haemorrhagic infarction 
SWC:   Sleep-wake cycling 
 
 
 
 
 
 
 
 
 
Note of the author on the terminology: 
The term postmenstrual age, which refers to the time elapsed between the first day 
of the last menstrual period and birth (gestational age) plus the time elapsed after 
birth (postnatal or chronological age), will be used in this script. The term 
postconceptional age however, referring to the time elapsed between the day of 
conception and birth plus the time elapsed after birth, which has been used in some 
of the cited references, will not be used because for reasons of clarity. Both terms 
refer to a similar concept of age of a preterm infant, the first one however, is the term 
conventionally used (1).  
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3. Introduction 
While advances in perinatal care have resulted in improved survival rates of very 
preterm infants over the last three decades (2, 3), the incidence of major neonatal 
complications causing significant morbidity in this population remains unchanged (4). 
Thus, very preterm infants represent a growing patient population at risk for cerebral 
injury and thus ND (5-8). As a consequence, the focus in neonatal intensive care 
units (NICU) lies on the implementation of monitoring, treatment, and prevention of 
brain lesion. Further, clinicians’ interest to get neurologic diagnostic and prognostic 
information already in early life period after birth is justified by the increasing amount 
of investigated neuroprotective agents and interventions (9, 10) that could find their 
threshold use in a near future. Prognosis of the outcome in preterms requires a broad 
approach and is based on neurological, neurophysiological, and neuroimaging 
findings (11). However, clinical neurological assessment of preterm infants in the 
early neonatal period is difficult since they are often clinically ill. Thus, detailed 
neurological examination often has to be delayed until they are clinically stable. 
Neuroimaging assessment in the NICU commonly includes serial cranial ultrasound 
(cUS) scans to detect cerebral injuries such as intraventricular haemorrhages (IVH), 
periventricular haemorrhagic infarction (PVHI), arterial stroke or white matter injury 
(12). Conventional and more advanced magnetic resonance imaging techniques 
such as diffusion tensor imaging and tractography, volumetry and morphometry 
provide more detailed information on the presence and extent of structural lesions of 
the white and grey matter compared to cUS (13, 14). However, this diagnostic 
procedure is difficult to perform during the very first days after birth in these critically 
ill preterm infants. Similarly, conventional EEG provides full spectrum information 
concerning the functional integrity of the brain, with relevant predictive value for 
outcome in preterm infants (15), but its feasibility 24 hours a day in the NICU for early 
neuronal function monitoring is limited due to restricted practicability and availability. 
The amplitude-integrated EEG (aEEG) however, is a user-friendly device, which can 
be easily used as a bedside neuromonitoring tool in the NICU. It provides immediate 
information on brain activity and its maturity, which is accessible also for EEG 
inexperienced clinicians. In the last 20 years aEEG began to play an ever-growing 
role in the evaluation of newborn infants admitted to a NICU. As a result, clinicians 
are increasingly faced with the interpretation or preterm aEEG. Little information is 
available however, concerning a) the evolution of maturational patterns of aEEG in 
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clinically stable preterms; b) the association between aEEG findings and cerebral 
lesions; and c) the association between aEEG findings and neurodevelopmental 
outcome. Knowledge on the evolution of maturational patterns of aEEG in preterms, 
and the factors influencing their trajectories may improve early detection of brain 
abnormalities and outcome prediction. That is of particular importance for the NICU 
clinician with respect to the direction of overall neonatal care and basis for 
neuroprotective intervention. 
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4. Population under focus: very preterm infants (APPENDICES I, II) 
While preterm birth (before the end of the 37th gestational week) accounts for 10–
13% of live births in high-income countries (16-18); very preterm birth (before the end 
of the 32nd gestational week) occurs approximately in 1% of live births (19), Swiss 
data being very similar to international one (20). Even though very preterm infants 
represent a small number of absolute live births, their need for intensive care 
medicine technology and the risk for long-term ND are of substantial public health 
relevance (21). In the last decades of the 20th century, their mortality rate constantly 
decreased, while neurodevelopmental morbidity remained almost unchanged (2, 3), 
which is still cause of major concern and explains the increased need for accurate 
long term outcome studies. Long-term outcome studies in the very preterm 
population group indicate higher vulnerability in a wide spectrum of developmental 
domains, ranging from somatic growth, learning abilities, behaviour, and motor 
performance to sensorial domains (5, 7, 8, 22-24). However, as design, prevalence 
of neonatal morbidities, characteristics of follow-up, and outcome variables vary 
substantially from study to study, a reliable comparison of their findings is difficult 
(25). The neonatal care policies concerning the care of preterm infants at borderline 
viability may further vary among different countries as well as within a country, which 
might also influence neonatal and long-term outcome figures. On overall, it is 
estimated that severe ND, usually defined as an aggregate comprising cerebral 
palsy, severe mental retardation, and severe visual or hearing impairment (23), reach 
a prevalence of approximately 10% in very preterm infants, while moderate-to-mild 
ND affects 30-50% of survivors. Moderate-to-mild deficits are more difficult to be 
detected during infancy and early childhood, but are also of major importance 
because of their high prevalence and because they may affect school performance 
and behaviour, and are cause of further burden for the families (26).  
 
4.1 Neonatal outcome of very preterm infants in Switzerland 
Recently, the Swiss Neonatal Network & Follow-Up Group (SNNFU), a health care 
professionals collaboration founded by the Swiss society of Neonatology, reported 
representative data on neonatal mortality and morbidities over a 12-years period, 
from 1996 to 2008 (20). They observed a significant increase of the birth rate of very 
preterm and very low birth-weight infants, i.e. with birth weight < 1500 grams, from 
0.9% in 1996 to 1.1% in 2008, an overall stable mortality rate of 13% during the 
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observational period, and a significant increase of survival free of major 
complications, defined as  major cerebral lesion, high staged retinopathy of 
prematurity, or bronchopulmonary dysplasia, from 67% to 72% (20). In a study on 
outcome of a Swiss national cohort of preterm infants born between the 240/7 and 
276/7 gestational weeks, we observed that mortality was mainly predicted by low GA 
and low birth weight, while antenatal corticosteroids to induce fetal lung maturation 
had a strong protective effect (27) (Appendix I). The observed rates in mortality and 
morbidity were similar to the findings of other European groups (28, 29), while 
compared to recent United States (30) and Australian cohorts (31), mortality was 
slightly higher. 
 
4.2 Two years outcome of very preterm infants in Switzerland 
Based on a national prospective database, we reported on the overall outcome at 2 
years of corrected age of in a Swiss cohort of extremely preterm infants, i.e. before 
the 280/7 gestational week, born over a nine-year period (2000 – 2008) (27) . In this 
recent and representative cohort study we demonstrate that although more than a 
third of infants still suffer from moderate or severe ND, the rate of survival without 
major neurologic sequelae has increased significantly over the first decade of this 
century. The incidence of severe ND was 11%, while 24% of infants survived with 
moderate ND. Interestingly, while adverse outcome, defined as death or severe ND, 
was predominantly dependant on GA, lower birth weight, and antenatal 
corticosteroids at birth, outcome at two years of age in children surviving the neonatal 
period was best predicted by the neonatal morbidities: major brain lesions as 
diagnosed by cUS, bronchopulmonary dysplasia, and retinopathy of prematurity (27). 
These findings are confirmed by other groups (32-34) and support the fact that the 
prognosis for preterm infants can substantially change during postnatal age (35) in 
function of the individual clinical course. 
 
4.3 Long-term outcome of former very preterms in young adulthood 
The outcome at young adult age in former very preterms has become object of 
increasing interest for many study groups during the last decade. Indeed, there is 
concern, whether and how prematurity affects late outcome, as defined by quality of 
life, and psychological functioning of this population. Previous studies report lower 
health utility scores in formerly extremely low birth weight (below 1000 grams at birth) 
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school-aged children and adolescents compared with peer controls (36). It seems 
however, that the effect of prematurity on quality of life diminishes over time (37) and 
that self-rated quality of life in young adulthood is generally surprisingly positive (38). 
Similarly, children and adults with chronic conditions and major handicap also 
perceived their quality of life close to normal (39, 40).The results of our study on 55 
young adults born preterm in Switzerland during the early 1980s with a birth weight 
below 1000 grams demonstrated that their self-perceived health status and mental 
health was overall satisfying (41) (Appendix II). The comparison with the community 
norms revealed however, that not all domains of quality of life are equally adjusted, 
the socio-emotional domain being specially affected (41). These data however, may 
not be representatives for the generations of preterm infants born during the last 
three decades, when perinatal care improved relevantly. 
While preterm birth has been associated with an increased risk of attention deficit 
and hyperactivity disorder (42) as well as of emotional disorders and autism (43) at 
adolescent age, it has been recently reported that preterm birth constitutes a single 
independent risk factor for a range of psychiatric diagnoses also at young adult age 
(44, 45). These findings are of major importance because not only cognitive and 
motor deficit but also psychological and behavioural disturbances may affect the 
social integration of the former preterm born individuals (26). 
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5. Amplitude-integrated electroencephalogram (aEEG) 
5.1 Generals on aEEG 
Until the late 1990’s continuous monitoring of the physiological parameters of a 
NICU’s patient was focussed and limited to heart rate, blood pressure, oxygen 
saturation, and body temperature. In the last 20 years however, continuous 
monitoring of the brain function by aEEG was integrated into the routine care and 
became a daily part of clinical surveillance of sick newborn infants in an increasing 
number of NICUs. The reasons of its rapid diffusion are to be found in its feasibility 
and easier interpretability compared to those of conventional EEG. Additional 
contributors are its good correlation with conventional EEG data, and, perhaps more 
important, its high sensitivity for predicting outcome during the first hours after birth in 
full-term newborn infants with neonatal encephalopathy following perinatal asphyxia 
(46). The constantly growing interest in long-term monitoring of the brain activity by 
aEEG in newborn infants follows the increasing knowledge and application of 
neuroprotective interventions in this patient population. 
 
5.1.1 aEEG history  
aEEG is a non-invasive method of brain activity monitoring, used in the intensive 
care of newborn infants since 1980. The method is however not new. A device for 
continuous EEG trend monitoring has been firstly developed with the name of 
‘cerebral function monitoring’ by Dr. Douglas Maynard in the late 1960’s in the UK 
(47, 48). Shortly later, his colleague Dr. Pamela Prior investigated its first clinical 
application on adult patients with status epilepticus, after cardiac arrest, and during 
anaesthesia. The term ‘cerebral function monitoring’ has been substituted by the 
term ‘amplitude-integrated EEG’, actually preferred in order to denote the method 
rather than specific equipment. In the late 1970’s, brain function monitoring by aEEG 
first focused on normal tracing in term and late-preterm newborn infants, as well as 
on the detection of clinical silent seizures (49-51). 
 
5.1.2 aEEG method  
aEEG is derived from a raw EEG signal. The first single channel aEEG devices 
usually recorded the EEG signal from a pair of biparietal electrodes placed in 
correspondence of P3 and P4 according to the EEG international 20-10 system, 
ground Fz (52). Thin subdermal needles-, disc hydrogel-, or cup electrodes are used. 
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While the information on brain activity is reduced to a trans-cerebral trace, and does 
not allow detection of hemispheric asymmetry, most of commercial aEEG devices 
offer nowadays the possibility to monitor brain activity from two centro-parietal 
channels placed upon both brain hemispheres, i.e. in correspondence of C3-P3 and 
C4-P4. That is of clinical significance, especially in infants with unilateral brain injury. 
The physiologic basis and aEEG engineering have been described in depth 
elsewhere (53), however following steps are to retain: 
- The raw EEG signal is amplified and passed through an asymmetrical band pass 
filter. This process strongly attenuates activity below 2 Hz and above 15 Hz and 
consequently minimizes artefacts from muscle activity, sweating or other electrical 
interferences.  
- The signal is then rectified. After this process, the monitor will display only 
positive amplitude voltage which reflects the peak-to-peak amplitude variation in the 
raw EEG. Thus, focus of the aEEG assessment becomes the trend of the amplitude 
variations of the raw EEG, while any analysis of grapho-elements or frequencies 
results beyond the bounds of possibility. 
- Further, the amplitude of the signal is semi-logarithmic compressed. The analysis 
of the lower amplitude ranges, linearly displayed until 10 µV on the y-axis of the 
monitor, is hence enhanced. That is particularly important in the voltage range below 
5 µV. 
- Finally the signal is time compressed and displayed on the x-axis at slow speed 
(1 hour per 6 cm). 
Figure 1 schematically displays the main steps of the aEEG signal processing. 
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Figure 1: Main steps of the aEEG signal processing (modified after El-Dib et al., 
2009 (54)). 
 
 
 
5.2 Rationale for the use of aEEG in preterm infants 
Information about the presence and extent of a brain lesion of newborn infants is 
preferably obtained within the first hours after its development. This is not only 
important to direct overall care and inform parents about their infant's current 
condition, but also to obtain predictive information about further outcome. Early 
selection of patients with neurophysiological monitoring by aEEG could also be 
useful for targeted diagnostic intervention such as neuroimaging or future 
neuroprotective intervention. aEEG helps to guide management of critically ill 
patients as it enables early identification of acute brain injury in preterm infants 
providing a continuous recording of the functional brain integrity around-the-clock 
immediately after admission in the NICU (55). Because of long periods of 
registration, aEEG is particularly useful to evaluate changes in the trend of the 
background pattern of the brain cortical activity over time and to detect the 
occurrence of silent or subclinical seizures. While video-conventional EEG remains 
the gold standard of neonatal electroencephalographic activity study, its feasibility in 
the NICU patient is limited. For a standard neonatal EEG, 9 electrodes are used to 
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produce 14 bipolar derivations together with channels for eye movement, muscle 
activity, and electrocardiogram. The standard duration of a conventional EEG 
recording lasts for approximately 30 minutes (56). This is very demanding if applied 
on an extremely and instable preterm newborn infant. 
In the last twenty years, a number of single- or bi-channel aEEG studies with 
simultaneous multichannel standard EEG were performed, demonstrating a very high 
concordance between the two techniques with respect to both the background 
pattern and the ictal activity in the sick newborn infant (46, 57-61). Thanks to long-
term brain function monitoring with aEEG, electrographic seizures are easier to 
detect and the efficacy of anticonvulsant therapies can be evaluated objectively 
during the monitoring period (55). 
 
5.3 aEEG tracing assessment 
Assessment of the aEEG focusses on the analysis of the background pattern, of the 
presence (or time of occurrence) and character of sleep-wake cycling (SWC) and 
finally of the presence of seizure activity. Basically, aEEG has been created as a 
bedside, analogical monitoring tool for visual pattern evaluation of the brain function. 
The development of new aEEG devices, more sophisticated and of digital nature, 
made it possible for the clinicians and researchers to perform quantitative analysis of 
aEEG parameters and of its correspondent EEG signal. The quantitative analysis of 
the maximum and minimum aEEG amplitudes helps to better define the bandwidth of 
the aEEG signal, which reflects the variations in the minimum and maximum EEG 
amplitudes. The maximum aEEG amplitude, or ‘upper margin’ of the aEEG 
bandwidth, is defined by the peak-to-peak amplitude of the EEG bursts, while the 
minimum aEEG amplitude, or ‘lower margin’ of the aEEG bandwidth, is defined by 
the peak-to-peak amplitude of the interburst EEG period (62) (see figure 2).   
The discontinuous EEG activity is quantified by the assessment of the percentage of 
discontinuity, the interburst interval [i.e. the period of so-called flat EEG 
(suppression), between two bursts of activity (periods of slow waves of high 
amplitude)], the burst frequency or the burst duration (63). Similarly, power spectral 
analysis of the raw EEG signal displays the quality of the electrocortical background 
activity. 
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Figure 2: Maximum (dotted line) and minimum (continuous line) aEEG amplitudes 
reflect the peak-to-peak amplitude variation during a cluster of activation and during 
the period between two clusters in the raw EEG, respectively (according to Rosèn, 
2006 (62)). 
 
 
 
5.3.1. aEEG background pattern 
Two different methods for the classification of the aEEG background pattern are 
defined and frequently used (see figure 3). 
 
5.3.1.1 The pattern classification 
In 2006, Hellström-Westas and associates published a aEEG trace classification (64) 
based on the visual perception of the dominating five different background patterns 
which correspond to the relative electrocortical activity: 
1) Continuous voltage pattern: background activity with minimum amplitude around 
(5 to) 7 to 10 μV and maximum amplitude of 10 to 25 (to 50) μV 
2) Discontinuous voltage pattern: background activity with minimum amplitude 
variable, but < 5 μV, and maximum amplitude > 10 μV 
3) Burst-suppression: discontinuous background with minimum amplitude without 
variability at 0 to 1 (2) μV (suppression) and bursts with amplitude > 25 μV. ‘Burst 
suppression +’ denotes a burst density ≥ 100 bursts per hour, while ‘burst 
suppression –’ means a burst density < 100 bursts per hour. 
4) Low voltage: continuous background pattern of very low voltage (around or < 5 
μV).  
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5) Inactive, flat: primarily inactive (isoelectric tracing) background < 5 μV. 
 
5.3.1.2 The voltage classification 
aEEG background can also be described in function of the voltage of the measured 
upper and lower aEEG amplitude. This classification system, published by Al Naqeeb 
and associates in 1999 (65), is based on the aEEG voltage range and distinguishes 
basically three backgrounds:  
1) Normal amplitude: lower margin of aEEG bandwidth > 5 μV and upper margin of 
aEEG bandwidth > 10 μV; 
2) Moderately abnormal amplitude: lower margin of aEEG bandwidth ≤ 5 μV and 
upper margin of aEEG bandwidth > 10 μV; and 
3) Severely abnormal amplitude: lower margin of aEEG bandwidth < 5 μV and upper 
margin of aEEG bandwidth < 10 μV. 
 
When the voltage classification system is used, care should be taken in case of an 
artefactual drift, i.e. a rise of the baseline. This can be frequently seen in severely 
depressed background pattern if extra-cranial electrical interferences occur, for 
example  electrocardiography (60). 
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Figure 3: The assessment of the aEEG consists in the recognition of the dominant of 
5 backgrounds according to a pattern or a voltage classification  
 
 
Modified after (66) on own examples of aEEG tracings. 
 
5.3.2 Sleep-wake cycling 
The observation of the aEEG tracing in a clinical stable newborn infant allows the 
recognition of a regular cyclic change in the background pattern. In the neurologically 
healthy term newborn infant this cyclic variation is typically smooth and sinusoidal, 
characterises mostly the minimum amplitude, and is called SWC. The broader 
bandwidth represents discontinuous background activity during quiet sleep (tracé 
alternant EEG in term infants), and the more narrow bandwidth corresponds to the 
more continuous activity during wakefulness and active sleep. 
According to Hellström-Westas and associates, aEEG SWC is classified as 
developed, imminent or immature, and absent SWC (64). Noteworthy however, the 
distinction of the transitions from sleeping and waking states in the child is not 
possible only through neurophysiological monitoring, but also through clinical 
(physiological and behavioural) observation, which is not seen in the aEEG. For that 
reason, some authors tend to define the aEEG background pattern variation in 
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newborn infant with the more neutral term of aEEG ‘cycling’ (67, 68) or ‘cyclicity’ (69-
72), especially in the preterm infant. This is of relevance as SWC is less defined in 
more immature and more instable newborn patients. Figure 4 depicts examples of 
the three described SWC features. In this script the mention “cycling activity” will be 
preferred. 
1) Developed cycling activity (SWC, in the original publication): clearly identifiable 
sinusoidal variations between discontinuous and more continuous background 
activity are observed, with cycle duration ≥ 20 min. 
2) Imminent/immature cycling activity (SWC, in the original publication): some, but 
not fully developed cycling activity of the lower amplitude is observed, but not 
developed as compared with normative GA representative data. 
3) No cycling activity (SWC, in the original publication). 
 
Figure 4: According to the Hellström-Westas and associates (64) aEEG cycling 
activity (SWC, in the original publication) is classified in three main forms: a) 
developed, b) imminent/immature, c) absent cycling activity. 
 
 
 
5.3.3 Seizures 
Seizures occur in approximately 50 per 1000 live preterm births, while in full term 
newborn infants, they occur in 1-3.5 per 1000 live births (73). The more immature or 
clinically instable the infant, the higher the probability of developing seizure activity 
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(74). However, Murray and associates observed in a video-conventional EEG study 
that only a minority of newborn infants show overt clinical signs of seizures, while in a 
majority of newborn infants, the clinical manifestations of electroencephalographic 
seizures are under recognized or misinterpreted even by experienced NICU staff (75, 
76). Subclinical seizure can be referred to the phenomenon of electroclinical 
dissociation or “uncoupling”,  characterised by reduced or absent clinical features 
during an ictal crisis associated with EEG seizure pattern (77-79). This phenomenon 
can be even more often observed in the immature and sick newborn infant after 
administration of anti-epileptic drugs (75, 78). Data about the incidence of subclinical 
seizures in the preterm newborn infant are still scarce. The application of aEEG for 
long-term monitoring of the brain activity allows the detection of this phenomenon 
and the differentiation of several seizure-associated behavioural patterns (i.e. oxygen 
desaturations or apneas) from non-ictal episodes (i.e. respiratory insufficiency). In the 
aEEG, ictal activity is seen as an abrupt rise in the minimum amplitude often 
accompanied by a simultaneous rise in the maximum amplitude. A short period of 
decreased amplitudes often follows this sudden pattern change (see figure 5). In the 
simultaneous review of the raw EEG attention should be paid to the typical features 
of seizure activity, with a gradual build-up and then decline in frequency and 
amplitude of repetitive stereotypical spikes or sharp-waves of activity with duration of 
at least 10 sec.  
According to Hellström-Westas and associates (64) seizure activity in the aEEG is 
classified as follows: 
1) Single seizure: a solitary seizure is observed. 
2) Repetitive seizures: single seizures appear more frequently than at 30-minute 
intervals. 
3) Status epilepticus: a continuously ongoing seizure activity for > 30 minutes is 
observed. 
It has been questioned whether single- or two-channel aEEG is a sufficiently reliable 
tool to detect epileptic activity. Because of the aEEG signal processing method, 
where both time and amplitude are compressed, and the limited number of 
electrodes used, focal seizure episodes of low-amplitude and short duration (< 30 
seconds) are hardly recognizable on aEEG (61). Furthermore, it can be difficult to 
distinguish between seizures and artefacts, for example due to handling of the infant 
or other electrical interferences. However, some aEEG/EEG studies have 
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demonstrated acceptable sensitivity for the detection of electrographic seizures, the 
C4–C3 derivation providing the best identification rate (75, 80, 81). The use of a two-
channel aEEG device and the simultaneous review of the raw EEG signal is 
therefore preferred for electrographic seizures detection in high risk newborn infants, 
particularly in the case of unilateral brain lesions. In case of difficult and doubtful 
aEEG traces with suspected seizures, it is suggested to perform video-conventional 
EEG exam as gold standard diagnostic method. 
 
Figure 5: aEEG tracings with corresponding raw EEG signal with examples of a) 
single, b) repetitive seizure activity, and of c) status epilepticus. 
 
5.a) Single seizure 
 
 
 
 
 
 
 
 
 
 
 
5.b) Repetitive seizures 
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5.c) Status epilepticus 
 
 
 
 
 
 
 
 
 
(BrainZ Instruments LTD, © 2004) 
 
5.4 aEEG interpretation caveats (APPENDIX III) 
Pitfalls in the interpretation of the aEEG background pattern have been well 
described in the last years (60, 61, 80-88). Basically, one has to be aware of 3 
fundamental caveats when assessing cortical activity of a preterm infant with aEEG. 
Noteworthy, beneath technical aspects which mainly concern the assessment 
equipment, also general clinical conditions and care of the NICU patient (63, 64) may 
affect the aEEG tracing. As a result, factors which may cause extra-cortical and/or 
cortical aEEG tracing modifications must be considered to avoid misinterpretation 
(Natalucci et al, submitted 2013). Evidences concerning the influence of other factors 
on aEEG activity in the preterm need to be confirmed in larger study populations. 
 
5.4.1 Caveat 1: electrodes location 
Recognition of the regional limitations of the use of such a simplified form of 
electroencephalography is important. While the “one-channel” aEEG perspective, i.e. 
electrodes P3-P4, provides general information about the brain function, with “two-
channel” mode, i.e. C3-P3 / C4-P4, it is possible to identify elementary signs of 
asymmetry in the cortical activity and eventually to localize the side of the injured 
region. Please see figure 6, where seizures are localized on the left side in the two-
channel aEEG tracing in an infant who developed a large left IVH (82). However, 
even if the optimal C3-P3 / C4-P4 electrode location allows the surveillance of a 
cortical area where about 60% of epileptic activity occurs in the newborn brain, it is 
still not possible to detect all seizures, nor their temporal development. Importantly, 
because of the aEEG signal processing where both time and amplitude are 
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compressed, the examiner will not be able to detect seizures episodes of short 
duration or low amplitude without reviewing the simultaneous raw EEG sequence. 
 
Figure 6: Regional limitations of single- and two-channels aEEG tracing. Right: T2-
weighted axial MR sequence showing a large left-sided IVH; repetitive seizures are 
observed on the single-channel (trans-cerebral, P3/P4) aEEG tracing of the same 
patient, but localised on the left side through the two-channel aEEG tracing. This 
case described in a recent Dutch publication has been chosen as example (82). 
Left: the C3/P3 electrodes location covers a watershed region between the perfusion 
areas of the anterior and middle cerebral arteries, and covers a brain cortical area 
where approximately 60% (89-91) of all seizure activity can take place in a newborn 
brain. 
 
 
A, M, P, perfusion area of the anterior, middle, and posterior brain artery, respectively; C3/P3, 
electrodes location. Modified after SA302011 LifeART Medical Illustrations Photograph Royalty Free 
(www.fotosearch.com). 
 
Electrode scalp location does not only determine the sensitivity of aEEG to detect 
seizure activity (81, 92) but seems also to significantly influence both the upper and 
the lower aEEG amplitudes, trans-central (C3-C4) aEEG values from term infants 
being significantly higher than trans-parietal (P3-P4) (87). Similarly, increasing inter-
electrode distance increases quantitative aEEG measures (87). 
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5.4.2 Caveat 2: aEEG artefacts 
Caution is recommended when assessing aEEG because artefacts contribute to the 
tracing rendering its readability problematic. aEEG artefacts are common during 
long-term recording and can be derived from mechanical as well as electrical 
interferences. The most frequently observed sources of artefacts are listed in table 1. 
Hagmann and associates reported that artefacts occurred in 12% of the 200 hours of 
aEEG recording randomly selected from a cohort of term newborn infants with 
neonatal encephalopathy following perinatal asphyxia (83). The ratio of occurrence of 
artefacts derived from movement and caused by electrical interferences was of about 
1:1. That may lead to erroneous classification of the aEEG trace. Similarly, Suk and 
associates observed that artefacts contribute substantially to the aEEG tracing also 
in preterm infants (84). 
Because of the relative frequent occurrence of artefacts in aEEG it is of primary 
importance to review real time and retrospectively both aEEG and its deriving raw 
EEG (61, 85, 86). 
 
Table 1: The most frequent artefacts and correspondent effect on aEEG tracing 
Artefact source Effect on aEEG tracing 
High-frequency oscillation 
Electrocardiogram 
Drifting of the lower bandwidth margin. Low voltage 
patterns of effective <1-2 μV are artificially displayed 
with higher lower bandwidth margin. 
Electromyogram 
Electrode padding 
Drifting of the lower and higher bandwidth margin. 
aEEG seizure-like features are artificially produced. 
Electrode positioning 
The measured voltage is function of the electrode 
distance. Electric bridges, caused by touching 
electrodes, result in an artificial isoelectric voltage. 
Application techniques 
Low impedance values, i.e. good EEG signal recording, 
results from a correct and standard electrodes 
application. 
 
As gold standard method, conventional EEG plays a clarifying role in the case of 
difficult or impossible interpretation, even if it allows only a momentary recording. The 
use of intradermal needles-electrodes and very low (0.1 to 5 kOhm) signal 
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impedance measurements over time allow high reduction of artefacts (60). In a 
recent study on the engineering aspects of the aEEG however, Quigg and associates 
demonstrated that, while high impedance mismatch distorts EEG and aEEG it does 
not significantly changes quantified aEEG measurement (87).  
 
5.4.3 Caveat 3: clinical confounders 
Another source of confounders is represented by the use of specific medications 
during aEEG monitoring (such as sedatives) or neonatal clinical variables (such as 
arterial hypotension) which are known to influence cortical activity and aEEG tracing. 
 
5.4.3.1 Effect of medications on aEEG 
Sedative, analgesic and antiepileptic drugs 
Central sedatives and analgesics, and antiepileptic drugs may lead to a transient 
suppression of cerebral activity (63, 88, 93-97), especially in sick infants with 
otherwise severely compromised cerebral function, and in very immature newborn 
infants in their early days of life. Morphine induces a suppression of the aEEG 
background tracing, when given in bolus injection (up to 100 µg/kg) or continuous 
injection (up to 12 µg/kg/h) in the very preterm newborn infant (93, 95) (Natalucci et 
al, submitted 2013). Niemarkt and associates published that a patient with moderate 
perinatal asphyxia, who received an accidental overdose (5000 µg/kg) of morphine 
developed a change of the background from continuous to discontinuous pattern 
(98). In contrast, we observed that intravascular continuous morphine administration 
(up to 40 µg/kg/h) did not induce any relevant aEEG change in cardiac newborn 
patients with GA above 32 weeks in the early post-surgery period (97) (Appendix III). 
We and others could demonstrate however, that bolus injections of stronger opioids 
than morphine, as fentanyl (up to 10 µg/kg) or sufentanyl (up to 0.5 µg/kg) induce 
severe suppression or even a transient flattening of the aEEG/EEG tracing in full-
term as well preterm newborn infants (97, 99). Our experience at the division of 
neonatology in Zurich, and that of other groups (64, 93, 95), is that a loading dose of 
phenobarbitone (up to 20 mg/kg) may result in a moderate depression of aEEG 
background activity in preterm. Similarly, newborn infants requiring bolus injection of 
midazolam, diazepam, or lorazepam (all up to 0.1mg/kg) show a transient depression 
of the aEEG activity, which is less marked in the full-term infants (64, 97, 100). 
However, both phenobarbitone and midazolam can induce a profound suppression of 
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the aEEG activity in the full-term newborn infants with neonatal encephalopathy 
following perinatal asphyxia, which may persist for a considerable period (101). The 
influences of lidocaine, given as a continuous injection (up to 4 mg/kg/h) for 
treatment of recurrent seizures often results in a discontinuous or burst suppression 
aEEG pattern (96, 100). 
Caffeine and aminophylline 
Arousing medications such as caffeine (loading dose of 10 mg/kg) (102) or 
aminophylline (loading dose of 5 mg/kg) (103), used for prevention and treatment of 
apneas, are also known to influence EEG/aEEG activity, both having been 
associated with an increase in aEEG background continuity. These finding are not in 
agreement with ours, where caffeine, given at a higher loading dose of 20 mg/kg, did 
not influence the aEEG tracing of 96 neurologically healthy preterms (Natalucci et al, 
submitted 2013). 
Indomethacin 
Data concerning the influence of indomethacin, given for closure of patent ductus 
arteriosus, is poor. In our experience indomethacin, given in a short duration infusion 
of 0.5 to 1 mg/kg, did not influence significantly the course of the aEEG recording 
over the first four days of life (Natalucci et al, submitted 2013). This is in agreement 
with Flisberg and associates who reported in a small group of preterm infants that 
indomethacin in similar doses as given in our centre does not affect cerebral function 
as evaluated by quantitative EEG (104). The aEEG analysis of the effect of 
indomethacin and of a haemodynamic relevant patent ductus arteriosus would be of 
benefit as both factors influence independently cerebral haemodynamic (105, 106). 
Surfactant 
Finally, it has been observed that in preterm infants, surfactant administration may 
result in a short transient aEEG depression parallel to a rise in cerebral blood volume 
as measured with near-infrared spectroscopy (107-109). The mechanism underlying 
the cortical activity suppression after surfactant therapy is object of controversy. In 
some studies infants with IVH were not excluded nor infants under phenobarbitone or 
sedative medication. Opioids sedation, as already mentioned, and intubation also 
alter cerebral function in the preterm infants (63, 110). An increase in cerebral blood 
volume has been observed after endotracheal surfactant instillation independently 
from major changes in the blood pressure or gases’ partial pressures (109) and with 
no negative effects on cerebral oxygen delivery and -extraction (108).That increase 
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in cerebral blood volume seems to be related to the volume of surfactant instilled 
(108, 111). That suggests that the volume of endotracheal instilled fluid may also 
play a role with respect to possible changes in cerebral oxygenation shortly after 
surfactant administration (111). In our experience we did not observe any relevant 
influence of surfactant administration on the aEEG tracing in preterm infants. Our 
population’s characteristics and clinical setting are however, different from those of 
the studies cited above. 
 
5.4.3.2 Effect of perinatal and neonatal factors on the aEEG tracing 
Chorioamnionitis 
Chorioamnionitis negatively affect the aEEG background of the very preterm infants 
early after birth. While the amplitudes of early aEEG are negatively associated with 
the presence of a clinically and pathohistologically defined chorioamnionitis 
(Natalucci et al, submitted 2013), early aEEG/EEG depression quantified by 
interburst interval is positively associated with the umbilical cord TNF-α (112). 
Small for gestational age 
We observed that preterm infants born small for GA, i.e. with birth weight below the 
10th percentile for GA, tend to display higher maximum aEEG amplitude during the 
first four days after birth (Natalucci et al, submitted 2013). That might reflect 
disorganised and dysmature pattern on conventional EEG with higher amplitude, 
characteristic of chronic stage abnormalities (113) in these growth retarded infants. 
Clinical instability 
It has been demonstrated by a Dutch group that severe illness as measured by the 
‘neonatal acute physiology score, SNAP-II’, and low blood pressure have a 
suppressive influence on aEEG in preterm patients (114). Severe hypoglycaemia 
(<1.0 mmol) has been described in a pilot study to cause transient depression of 
aEEG background (115), while mild hypoglycaemia seems to relate to no (116) or 
only (117) subtle changes in the EEG amplitude. A case of decreased aEEG 
background activity during neonatal pneumothorax has been reported in the past 
(115). 
Unconjugated hyperbilirubinaemia 
Unconjugated hyperbilirubinaemia is known to acutely expose preterm infants to 
further neurodevelopmental risk. Although EEG amplitude is negatively related to 
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bilirubin levels (118), the observed aEEG bilirubin-related changes are modest, 
transient and delayed from 1 to 2 weeks after the measured event. 
NICU interventions 
Music has also been shown to influence the aEEG pattern in neurologically healthy 
late-preterm and term newborn infants, where a trend to more mature cycling aEEG 
activity was observed compared to not music-exposed controls (119). That finding is 
of relevance considering that music is being increasingly used in the context of 
neurodevelopmental care in NICUs, as a valuable resource to reduce stress and 
increase physiological stability (120). 
 
5.5 aEEG in preterm infants 
The interpretation of the aEEG of the immature brain of preterm infants is additionally 
more problematic than in term infants (a) because of its own specific background and 
cycling character and (b) because it is apparently influenced by brain maturity, which 
can be defined by the GA, and by the time of extra-uterine brain exposition, defined 
as the postnatal age. 
a) The aEEG background activity is primarily discontinuous in the very preterm 
infants, where this pattern is normal, and develops to a predominantly continuous 
aEEG background pattern until the 35-36th postmenstrual week. It is important to 
distinguish between the normal discontinuous aEEG (in the EEG this is called ‘tracé 
discontinu’), and the abnormal burst suppression pattern (refer to figure 3). While the 
first is characterized by variable, lower aEEG amplitude activity of 0 to 5 µV, the latter 
shows a straight, almost not variable lower aEEG amplitude of 0 to 1 µV, 
corresponding to the inactive suppression period observed in the conventional EEG. 
Cyclic aEEG bandwidth variations suggestive of immature SWC emerge in stable, 
neurologically healthy preterm infants as soon as the 25th to 26th week of gestation is 
reached, and progressively develop until being definitely recognized at the 31st to 
32nd postmenstrual week (68, 88, 121, 122) (Natalucci et al, submitted 2013) (see 
figure 7). 
b) The normal aEEG background of preterm infants changes with GA, which may 
define cerebral maturation at birth, and with postnatal age, which may define the time 
of extra-uterine brain exposition (57, 68, 123-125) (Natalucci et al, submitted 2013). 
As a result, while assessing preterm aEEG it is essential to be aware of both time 
factors in order to define normality in function of the infant maturity. 
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Normative values of aEEGs are of relevant clinical utility for the identification of 
maturational brain disturbances or dysfunctions in this population group. However, 
age-adequate aEEG norms concerning qualitative or quantitative characteristics in 
preterm infants are scarce. Based on the results of previous studies published 
between 1984 and 2004, Hellström-Westas and associates summarised normal 
aEEG tracing characteristics at different GA (64) shown in table 2. 
Olischar and associates published in 2004 reference values for aEEG in clinically 
stable and neurologically normal preterm infants with GA below 30 weeks during their 
first two weeks of life (123). They objectivize an increase in the continuity of the 
aEEG background in function of GA, reporting the percentages of the different 
background patterns and the percentiles as reference for preterm infants below 30 
week GA. However, they did not describe the postnatal development of the aEEG 
tracings. 
 
Figure 7: aEEG background pattern changes in function of brain maturity as defined 
by the postmenstrual age. The cycling character of the aEEG tracing emerges with 
increasing GA/PMA. Modified after (68). 
 
 
 
The norms provided by Zhang and associates in 2011, ranging from 30 to 55 weeks 
PMA, were based on the largest dataset published to date (125). In agreement with 
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other groups (95, 123, 126) (Natalucci et al, submitted 2013) they showed that 
continuity, and both the lower and upper aEEG amplitudes, as well as the aEEG 
bandwidth develop with increasing PMA (125). They did not report however if those 
norms are influenced by the GA. We and others reported that aEEG developmental 
trajectories change over the postnatal period in function of GA (77, 95) (Natalucci et 
al, submitted 2013). 
 
Table 2: Normal aEEG characteristics in preterm infants at different GA/PMA. 
Modified after (64). 
 Qualitative aEEG characteristics Quantitative aEEG/EEG characteristics 
GA or PMA 
(weeks) Background 
1 Cycling activity aEEG minimum amplitude (μV) 
aEEG maximum 
amplitude (μV) Bursts/hour 
24 – 25 D Imminent/immature 2 – 5 25 – 50 (100) > 100 
26 – 27 D Imminent/immature 2 – 5 25 – 50 (100) > 100 
28 – 29 D / (C) Imminent/immature, Developed 2 – 5 25 – 30 > 100 
30 – 31 C / (D) Developed 2 – 6 20 – 30 > 100 
32 – 33 C / D in QS Developed 2 – 6 20 – 30 > 100 
34 – 35 C / D in QS Developed 3 – 7 15 – 25 > 100 
36 – 37 C / D in QS Developed 4 – 8 17 – 35 > 100 
Dominating aEEG background pattern; D, discontinuous background pattern; C, continuous 
background pattern; QS. quiet sleep 
 
According to that observation, it seems that, for a given PMA, infants with lower GA 
might have a more continuous cerebral activity than others, which still is of unknown 
predictive value (see figure 8). External stimuli experienced by the preterm infant 
during the stay in NICU might be a cause of the “accelerated” extrauterine 
development of cortical activity. Thus, while defining the norms for measurable aEEG 
parameters in the preterm infant it is important to simultaneously consider both GA 
and the actual postnatal age of the patient at which the aEEG assessment has been 
done. 
Burdjalov and associates (68) developed a valid scoring system allowing the 
evaluation of the maturity level of aEEG tracings of preterm infants.  This score, 
based on visual qualitative and quantitative measurements of four aEEG 
components, allowed them to demonstrate that the brain maturation of newborn 
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infants can be followed and quantified by aEEG monitoring. Following aEEG aspects 
are analysed: a) the ‘continuity’ of  aEEG trace; b) the ‘cycling’ character of  aEEG 
trace; c) the average ‘minimum aEEG amplitude’ (or the lower margin of the aEEG 
bandwidth); and d) the aEEG ‘bandwidth’. Each component is scored and individual 
values are summed to determine a ‘maturity total score’ for the aEEG tracing, 
ranging from 0 to 13, the lower the score the more immature the brain activity. The 
highest total scores are reached at 35 to 36 weeks of postconceptional age. 
 
Figure 8: aEEG tracings of a preterm newborn boy of the 26 2/7 week GA at 1, 2 
and 4 days after birth. Qualitatively, the tracing characteristics are scored 2, 6, and 8 
according to (68), respectively. That reflects maturity total scores which are typical for 
GA/PMA 24-25, 27-28, and 29-30 weeks, respectively. 
 
     
 
1. day after birth 2. day after birth 3. day after birth 
Maturity total score = 2/13 Maturity total score = 6/13 Maturity total score =8/13 
Continuity = 0/2 Continuity = 1/2 Continuity = 2/2 
Cycling = 0/5 Cycling = 1/5 Cycling = 2/5 
 
A limitation in all efforts aimed to define normal values for aEEG tracing in the 
preterm infant is represented by the fact that qualitative assessments (i.e. scores) 
may imply a certain degree of subjectivity which may affect inter-rater agreement.  
 
5.6 Prognostic value of aEEG in preterm infants (APPENDICES IV, V) 
Studies on the clinical utility of aEEG in the NICU have been mainly focussed on the 
management of term infants affected by neonatal encephalopathy following perinatal 
asphyxia. In those patients, early aEEG monitoring, i.e. within 6 h after the asphyctic 
event, revealed to be predictive for adverse short- (127, 128) and long-term (129) 
outcome in cohorts of the ‘pre-cooling era’, i.e. before the introduction of therapeutic 
hypothermia. To date, three studies have reported predictive values of continuous 
aEEG monitoring in encephalopathic newborns being treated with hypothermia. They 
suggested that, even if aEEG in the first 24–48 hours of life may have limited 
predictive value in cooled patients, the persistence of aEEG background abnormality 
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after 48 hours and the lack of SWC recovery after 60 hours confers higher certainty 
of adverse outcome (66, 130, 131). 
Early prediction of neurodevelopmental outcome with aEEG is more complicated in 
the very preterm infants than in term newborn infants, as it has been already 
observed with respect to the aEEG tracing interpretation. The dominant aEEG 
background pattern in very and extreme preterm newborn infants is discontinuous, 
with variable feature reflecting maturational changes in the developing brain. As a 
result, norm values and a classification system based on the type of background 
pattern have not been definitely identified for the preterm population. While the 
recognition of the absence of cycling activity is a relative evident task, normative 
references for the distinction and scoring of different grades of dysmature cycling are 
still limited. Further, neurodevelopmental outcome in the preterm infant is not only 
determined by brain lesions, which may possibly be detected by aEEG monitoring, 
but also by neonatal morbidities as bronchopulmonary dysplasia, retinopathy of 
prematurity, sepsis, as well as sex and socio-demographic factors (27, 132). In that 
perspective, some groups have studied the predictive value of early aEEG in preterm 
newborn infants with respect to the neonatal outcome (69, 70, 72, 74, 88, 112, 133-
140). The assessment of the predictive value for the neurological long-term outcome 
of preterms by aEEG tracing however, still remains limited. 
In a cohort of very preterm newborn infants we could observe that the functional 
brain maturity early after birth, as measured by aEEG during the first 3 days of life, 
significantly correlates with the structural brain maturity, as qualitatively assessed on 
cranial magnetic resonance imaging (cMRI) at term equivalent. Figure 9 displays two 
opposite examples of (figure 9.1) infant with partially absent aEEG cycling activity 
over the first four days of life with the correspondent cMRI sequence with features of 
immaturity and atrophy, and (figure 9.2) infant with relevant cycling increase on 
aEEG tracings over the observational time with correspondent normal cMRI 
sequence at term equivalent (141) (Appendix IV).  
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Figure 9.1: Development over time of the aEEG background between day 1 and 3 
after birth in a preterm newborn girl of 27 5/7 weeks of gestation: a) prevalently burst 
suppression aEEG background pattern at day 1 after birth with total maturity score 
2/13; b) progressively discontinuous aEEG background pattern with variable 
minimum aEEG amplitude below 5 μV and total maturity score 2/13; and c) axial T2 
weighted MR image at 38 0/7 weeks PMA; Scores: germinal matrix 3, cortical folding 
2, myelination 2, bands of migration 2, total maturation score 9/21. (141) 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.2: Development over time of the aEEG background between day 1 and 3 
after birth in preterm newborn girl of 27 4/7 weeks of gestation: a) prevalently 
discontinuous aEEG background pattern at day 1 after birth with total maturity score 
6/13; b) progressively continuous aEEG background with more mature cycling 
activity and total maturity score 8/13; and c) axial T2 weighted MR image scanned at 
41 0/7 weeks PMA. Scores: germinal matrix 4, cortical folding 3, myelination 2, bands 
of migration 4, total maturation score 14/21. (141) 
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5.6.1 Prognosis of neonatal outcome 
Much data from conventional EEG studies shows that the electrocortical activity is an 
early marker of brain damage in preterm infants during the first weeks after birth 
(142-144). The meaning of abnormal aEEG tracing early after birth in terms of 
neonatal outcome in preterm infants has been investigated by some groups since the 
late 1980’s (133, 134). Recently, predictive values for abnormal aEEG background 
have been reported (69, 88, 135). However, both aEEG abnormalities and neonatal 
outcome are heterogeneously defined. Quantitative measurements of the degree of 
continuity of the aEEG background are obtained by visual analysis, percentage 
assessment of activity above a predefined voltage level (i.e. 3 or 5 μV), or burst 
frequency assessment. Neonatal outcome is generally defined in the literature as a 
major neurological complication, i.e. grade III IVH or PVHI according to Volpe (145) 
or cystic periventricular leukomalacia (cPVL), or death. 
 
aEEG Background 
The main aEEG background abnormality characterizing the tracing of preterm infants 
with poor neonatal outcome compared to that of GA-matched controls, is amplitude 
suppression (69, 72, 112, 135-137, 139, 146). Figure 10 displays the aEEG tracing of 
a 2 days old preterm girl, born at 27 6/7 weeks of gestation, which is characterized by 
sudden amplitude suppression (continuous arrow). The discontinuous background 
pattern changes abruptly to a burst suppression pattern, with periods of relative long 
cortical suppression (dashed arrows). That episode occurred in a period when the 
infant was stable and corresponded to the development of a bilateral grade III IVH 
according to (145) diagnosed by cUS 6 hours later, with later development of 
posthaemorrhagic hydrocephalus. 
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Figure 10:  aEEG tracing of a 2 days old preterm girl with developing bilateral grade 
III IVH according to (145). Sudden amplitude suppression (continuous arrow) with 
abrupt change from discontinuous pattern to burst suppression, with long 
suppression periods (dashed arrows). 
 
 
 
The role of aEEG as additional tool for the evaluation and management of preterm 
infants with posthaemorrhagic hydrocephalus has been recently reported by 
Klebermass and associates (140), who reported in 13 of 17 patients an aEEG 
background deterioration before clinical signs of elevated intracranial pressure 
occurred, and a normalisation within a week of successful neurosurgical intervention 
for cerebrospinal fluid removal. 
Concerning the predictive values of an abnormal aEEG background pattern observed 
early after birth in preterm infants, two studies (69, 137) reported amplitude 
suppression, defined by a decrease in the tracing continuity, as a sensitive marker for 
poor neonatal outcome (acute brain injury as above described or death). Please see 
table 3 for further details. A third recent study (135) however, provided rather high 
specificity and positive predictive values (PPV). This is probably the consequence of 
the fact that the cut-off for amplitude suppression, i.e. low amplitude voltage or burst 
suppression (pathologic at any GA), was quite lower than in the other studies. 
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Table 3: Predictive values of amplitude suppression on early aEEG  
for death, P/IVH, cPVL. 
Patients (n) aEEG within Sensitivity Specificity PPV NPV Outcome Ref 
<29 week GA (65) 48h ab 83% 77% 45% 95% Death / P/IVH (137) 
<32 week GA (115) 12h – 72h ab 89% 61% - - P/IVH / cPVL (69) 
<29 week GA (30) 48h ab 57% 100% 100% 85% P/IVH (135) 
GA, gestational age; h, hours; ab, after birth; PPV, positive predictive value; NPV, negative predictive 
value, Ref, reference; P/IVH, grade III intraventricular haemorrhage and periventricular haemorrhagic 
infarction according to (145); cPVL, cystic periventricular leukomalacia. 
 
aEEG cycling 
Similarly, aEEG cyclicity is less commonly observed in preterm infants with poor 
neonatal outcome compared to GA-matched controls (69, 70, 72, 136, 137, 139). In 
such cases cycling activity can be completely absent during prolonged periods after 
birth or may be present without any sign of adequate maturation as depicted in the 
sequences of figure 11. Additionally, loss of aEEG cycling activity is associated with 
development of posthaemorrhagic hydrocephalus in preterm infants (147). 
 
Figure 11: aEEG tracing of a preterm infant at the 31 week PMA with bilateral grade 
III IVH according to (145). No adequate maturation of the aEEG cycling activity is 
evident. The aEEG tracing of a neurologically healthy preterm infant at similar PMA is 
shown as reference. 
 
 
 
With repeated measures analysis we investigated the trajectories over the first four 
days of life in very preterm newborn infants, looking at the characteristics of the 
developmental patterns. We observed that, while some infants showed no evident 
development of aEEG cycling activity as depicted in the aEEG sequences a) of figure 
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12, the majority of infants displayed a relevant cycling increase during the 
observational period as depicted in the aEEG sequences b) of figure 12. Looking for 
possible trajectory differences between preterm infants with severe, mild and no 
brain lesions as observed by cUS, we noticed that preterm infants with severe brain 
lesions had a significantly slower development of the aEEG cycling activity compared 
to those with mild or no brain lesions (72) (Appendix V). This finding remained 
significant after adjustment for differences in GA, birth weight, illness severity score, 
and sedation. 
 
Figure 12: aEEG tracing at day 1 and day 4 after birth of two preterm newborn 
infants a) with and b) without major IVH. In case a) no evident sign of maturation of 
the cyclic aEEG activity is observed, while in case b) displays a relevant cycling 
increase during the short observational period. 
 
 
 
The results of three studies are summarized in table 4 with respect to the predictive 
values of the absence of cycling activity for poor outcome (defined as mentioned 
above). The first two studies (69, 137) reported similar high specificity and negative 
predictive value (NPV), though different outcomes, and different timing of aEEG 
assessment between the studies. Finally, a Japanese study (70) reported a 
specificity and NPV of 100% of early aEEG for the prediction of cPVL in a group of 
12 preterm infants. 
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Table 4: Predictive values of absent cyclicity on early aEEG for death; P/IVH; cPVL. 
Patients (n) aEEG within Sensitivity Specificity PPV NPV Outcome Ref 
<29 week GA (65) 48h ab 75% 77% 43% 93% Death / P/IVH (137) 
<32 week GA (115) 12h - 72h ab 63% 81% - - P/IVH / cPVL (69) 
<32 week GA (12) 24h ab 100% 89% 75% 100% cPVL (70) 
GA, gestational age; h, hours; ab, after birth; PPV, positive predictive value; NPV, negative predictive 
value, Ref, reference; P/IVH, grade III intraventricular haemorrhage and periventricular haemorrhagic 
infarction according to (145); cPVL, cystic periventricular leukomalacia. 
 
aEEG seizures 
Seizures are known to occur more commonly in preterm infants with poor neonatal 
outcome compared to GA-matched controls (74, 88, 133, 136, 139), as it was the 
case of a late preterm infant with status epilepticus, shown in figure 13, associated to 
sinovenous thrombosis with large bilateral PVHI.  
 
Figure 13: aEEG recording showing typical saw-tooth tracing corresponding to a 
status epilepticus in a late preterm newborn boy with sinovenous thrombosis. The 
raw EEG tracing shows epileptic activity on the left side, while suspected epileptic 
activity on the right side seems to be distorted by artefactual interferences. 
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Shah and associates reported that electrographic seizures in preterm infants 
observed during the first week of life by aEEG trend analysis (22% of 51 infants) are 
significantly associated with cerebral injury documented by cMRI exam and neonatal 
death (74). In table 5 the predictive values for both outcomes are shown. The low 
PPV of the early occurrence of electrographic seizures in preterm infants as 
observed by continuous aEEG monitoring is explained by the fact that in that study, 
among infants with seizures, a relevant proportion suffered from major neonatal 
complications other than cerebral injury, like necrotising enterocolitis for instance. 
Thus, the absence rather than the occurrence of seizures was predictive in this 
cohort (74). 
 
Table 5: Predictive values of seizures on early aEEG for death and P/IVH.  
Patients (n) aEEG within Sensitivity Specificity PPV NPV Outcome Ref 
<30 week GA (51) 4d – 5d ab 45% 95% 71% 86% Death (74) 
<30 week GA (51) 4d – 5d ab 53% 94% 82% 80% P/IVH (74) 
GA, gestational age; d, days; ab, after birth; PPV, positive predictive value; NPV, negative predictive 
value, Ref, reference; P/IVH, grade III intraventricular haemorrhage and periventricular haemorrhagic 
infarction according to (145). 
 
5.6.2 Prognosis of outcome at early childhood  
The correlation of aEEG tracing with later neurodevelopmental outcome in the 
preterm infants has not yet been broad investigated compared to the neonatal 
outcome analysis described above. Whether there is an optimal time point in 
assessing aEEG pattern for best prediction still remains an open question. Acute 
EEG stage abnormalities, characterized by acute amplitude depression, and chronic 
stage EEG abnormalities, characterized by disorganized patterns and delayed 
maturation (or dysmaturity), are associated with brain injuries and correlate with 
further neurodevelopment (113, 139, 148). Most of the acute changes of the EEG 
background are transient and gradually resolve later, being replaced by “chronic-
stage” changes. Therefore, it is of interest to provide information concerning both 
EEG changes while monitoring brain function, which is probably best performed by 
prospectively repeated exams. There is some evidence that aEEG recording from the 
first two weeks after birth may display the best predictive values, while thereafter 
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predictive power is decreasing (149). As already mentioned, the analysis of aEEG 
tracing recorded during the first few days after birth requires particular attention 
because of the relative higher rate of possible confounders during that early life 
period, which may interfere with the tracing interpretation and may cause false 
negatives. Many changes in respiratory (respiratory distress, mechanical ventilation) 
and hemodynamic status (i.e. arterial hypotension, closure of patent ductus 
arteriosus) may occur, and the rate of intensive medical intervention and medication 
(i.e. sedation, arousing drugs) is more frequent in the first two weeks of life than 
thereafter (149). To date, three groups reported the predictive values of early aEEG 
for preterm outcome during early childhood as defined as 1.5 to 3 years of corrected 
age (71, 140, 150), some others reported the association between early aEEG 
abnormalities and further outcome in preterms (112, 146). The predictive values of 
decreased continuity, absent cycling activity, and seizure occurrence on early aEEG 
tracing for adverse outcome, defined as death or ND in preterm survivors, are 
reported in the following paragraphs.  
 
aEEG background 
aEEG background activity characterized by prolonged periods of amplitude 
suppression, defined as prolonged interburst period or decreased continuity, provides 
predictive outcome information within the first days of life (112, 149, 150). This has 
been reported for preterm infants with large IVH (88), but also irrespective of brain 
damage and GA at birth (71). Table 6.1 shows the predictive values of decreased 
continuity of aEEG background for poor outcome at early childhood in preterm 
infants. Despite the heterogeneity of the values, being partially explained by 
differences in the outcome definitions, there is a quite recognizable decrease in the 
false positive rate during the first weeks of life. Predictive data of EEG continuity 
measurements in the West and associates’ study (150) were slightly lower compared 
with those of a neurophysiologist’s interpretation, assessing interburst interval, 
waveforms and seizures together. In fact, visual expert examination provided lower 
false positives, with a sensitivity of 63%, specificity of 93%, PPV and NPV of 75% 
and 88% for adverse outcome at 15 months, respectively (150). Quantitative 
aEEG/EEG data, as the highest burst rate per hour (which correspond to the best 
background) provided comparable predictive information to the aEEG qualitative 
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assessment, without further increase in the prognostic accuracy (71) (tables 6.1 and 
6.2). 
 
Table 6.1: Predictive values of decreased continuity for death or ND 
at early childhood. 
Patients (n) aEEG within Sensitivity Specificity PPV NPV Ref 
<29 week GA (76) 1d – 2d ab 58% 72% 41% 84% (150) 
<30 week GA (49) 1d – 3d ab 89% 53% 54% 89% (71) 
< 30 weeks GA (148) 2w ab 68% 95% 95% 69% (149) 
  
 
 
 
 
 
 
 
 
 
Table 6.2: Predictive values of increased interburst interval for death or ND 
at early childhood. 
Patients (n) aEEG within Sensitivity Specificity PPV NPV Ref 
<30 week GA  (49) 1d – 3d ab 89% 67% 63% 91% (71) 
<33 week GA (64)* 2d ab 70% 92% 95% 60% (88) 
ND, Neurodevelopmental disability; GA, gestational age; d, days; w, weeks; ab, after birth; 
PPV, positive predictive value; NPV, negative predictive value, Ref, reference; * with grade 
III periventricular or  periventricular haemorrhage according to Volpe (145). 
 
aEEG cycling 
Hellström-Westas and associated reported that the presence of aEEG cycling activity 
during the first week after birth in preterm infants suffering from high grade IVH is 
associated with fair outcome (survived healthy or with mild cerebral palsy) at two 
years of corrected age (88). Concerning aEEG predictive data, the absence of 
cycling activity on early aEEG seems to be a quite specific marker of poor outcome in 
early childhood as demonstrated by table 7, which again displays the few 
corresponding data from the literature. In opposition to the other aEEG assessment 
components, absent cycling activity still provide high specific prediction of poor 
outcome until the fourth week of life (149). (Table 7) 
 
aEEG seizures 
Among all aEEG assessment components, seizures detected on continuous cot-side 
electroencephalogram seem to provide the lowest predictive values. Table 8 shows 
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predictive values of seizures detected by aEEG for poor outcome at early childhood 
in preterm infants (71, 149, 150). Seizures are markers of cerebral dysfunction and 
are associated with the development of neonatal neurological complication (high 
grade IVH, cPVL, meningitis) and with abnormal outcome (74, 151). However, 
prediction of poor outcome by recognition of seizures by aEEG recording may be low 
because of two main limiting factors. On the one hand, the suboptimal level of 
accuracy of aEEG with respect of seizure detection (80) may explain the high false 
negative rate observed in two of three studies. The discrimination between abnormal 
neuronal activity and artefacts may be difficult and further interfere with seizure 
detection. On the other hand, long-term outcome of preterm infants may not only be 
determined by a transitory neurological dysfunction, detected in form of seizure 
activity in the aEEG tracing, but also by other neonatal morbidities. That may explain 
the higher false positive rate observed in one of three studies. It still remains to be 
determined whether long-term outcome in preterms may be influence by seizure 
management (152). (Table 8) 
 
Table 7: Predictive values of absent cycling activity for death or ND 
at early childhood. 
Patients (n) aEEG within Sensitivity Specificity PPV NPV Ref 
<30 week GA (49) 1d – 3d ab 58% 77% 61% 74% (71) 
<30 week GA (148) 2w ab 47% 96% 96% 50% (149) 
ND, Neurodevelopmental disability; GA, gestational age; h, hours; w, weeks; ab, after birth; 
PPV, positive predictive value; NPV, negative predictive value, Ref, reference. 
 
Table 8: Predictive values of seizures for death or ND at early childhood. 
Patients (n) 
aEEG 
within 
Sensitivity Specificity PPV NPV Ref 
<29 week GA (76) 1d – 2d ab 26% 100% 100% 80% (150) 
<30 week GA (49) 1d – 3d ab 44% 43% 40% 47% (71) 
<30 week GA (148) 2w ab 11% 98% 87% 50% (149) 
ND, Neurodevelopmental disability; GA, gestational age; h, hours; w, weeks; ab, after birth; 
PPV, positive predictive value; NPV, negative predictive value, Ref, reference. 
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Comparison with other neurologic assessment tools 
Table 9 listed non-adjusted odds ratios for poor outcome at early childhood as 
defined by abnormalities observed during the first two weeks of life or at term 
equivalent age by four different neurological diagnostic tools from three different 
studies on similar preterm populations. Data relates to aEEG, as defined by a sum 
abnormality score, including background, cycling activity and seizure occurrence 
(149); severe-to-moderate abnormalities on conventional EEG (15); major brain 
lesions on cUS (149); and moderate-to-severe white matter abnormalities on cMRI 
performed at term equivalent age (12). 
 
Table 9: Non-adjusted odds ratios (95% confidence intervals) for poor outcome 
at early childhood of abnormalities on aEEG, EEG, cUS during the first two 
weeks of life, respectively, and cMRI at term equivalent age. 
Abnormal: 
At: 
 
aEEG 
2. week ab 
(n = 143) 
EEG 
2. week ab 
(n = 278) 
cUS 
2. week ab 
(n = 143) 
cMRI (WM) 
40. week PMA 
(n = 167) 
DQ < 70 
16.9 
(3.9-72.4) 
6.9 
(2.6-19) 
7.8 
(2.1-29.3) 
 
 
 
3.6 / 10.3 * 
(1.4-8.7 / 3.5-30.8) 
Cerebral 
palsy 
14.7 
(4.3-50.3) 
12.1 
(4.5-32.0) 
13.4 
(3.9-46.0) 
9.5 
(3.2-28.3) 
Death 
8.1 
(1.4-45.1) 
- 
9.3 
(1.6-51.9) 
- 
 
Klebermass 
et al., 2011 
(149) 
Hayashi-Kurakashi 
et al., 2012 
(15) 
Klebermass 
et al., 2011 
(149) 
Woodward 
et al., 2006 
(12) 
     
ab, after birth; cUS, cranial ultrasound scan; PMA, postmenstrual age; cMRI (WM), cranial magnetic 
resonance imaging (white matter); DQ, developmental quotient, < 70 reflects an index below – 2 
standard deviations from the norm 100 for mental or motor performances in (149) and (15); in (12) 
data about mental development and psychomotor developmental index, according to the Bayley’s 
scales of infant development, II edition (153) are reported separately; cerebral palsy is defined 
according to (154) in (15) and (12). 
 
Concerning the timing of aEEG assessment with respect to the outcome prediction, 
Klebermass and associates reported that the predictive value of aEEG for outcome in 
early childhood constantly increased, reaching its maximal values at the second 
week of life, while the absence of cycling activity alone remained a very specific 
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marker for poor outcome until the fourth week of life (149). They reported only a 
slight decrease of the predictive values (especially for the NPV) of cUS for poor 
outcome over the first four weeks of life. Hayashi-Kurakashi and associates shown 
that according to unadjusted analysis, EEG abnormalities in any time period within 
the first month of life significantly predicted poor neurodevelopmental outcome in 
preterm infants, while major brain lesions detected by neuroimaging techniques (cUS 
or cMRI) had the highest odds ratios (15). It seems however, that abnormal 
functional EEG findings precede structural abnormalities observed on cUS, 
consistent with previous reports (67, 137). cMRI in preterm infants at term equivalent 
age allows better quantification of differences in brain morphology than cUS (13, 14). 
In a recent review, Plaisier and associates investigated how cMRI in preterm infants 
should be timed to best predict long-term outcome. Based on literature data, they 
suggested that the cMRI should preferably be performed at term-equivalent age, as 
the individual prognostic information provided by brain magnetic resonance scanning 
at that period of life seems to be superior to that provided by early cMRI (155). 
Furthermore, cMRI exam before term equivalent age in preterm infants is more 
challenging for the more vulnerable, respiratory and thermoregulatory instable patient 
during the first few days after birth. 
Data on the association between the assessment of the general movements, 
comparable to those of table 9, i.e. about exclusively preterm infants with similar GA, 
similar outcome measures and similar statistical analysis have not been published 
yet. This functional assessment of the neurological integrity of the NICU patient with 
high predictive value for the long-term neurodevelopment of full-term newborn infants 
(156), merits to be mentioned. The timing of this method has been defined in function 
of the quality of movements at three age groups according to a standard, namely 
preterm, writhing (i.e. term), and fidgety (i.e. third month after term) periods, the 
fidgety period providing the best predictive validity (156, 157). Two studies reported 
predictive values of the assessment of general movements for the development of 
cerebral palsy in preterm infants with GA below 32 (102 infants) (158) and 30 (86 
infants) (159) weeks, at the corrected age of 18 and 12 months, respectively. 
Abnormal general movements assessed during the 36th to 44th week PMA (the 
writhing period) provided following predictive values: sensitivity 62-100%, specificity 
of 40-69%, PPV 9-29% and NPV 100-90%, while during the third month after term 
(the fidgety period) the results were as follows: sensitivity 50-100%, specificity 81-
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86%, PPV 0.3-41%, and NPV 90-100% (158, 159). Interestingly, it has been recently 
reported that combining abnormal general movements at 3 months of corrected age 
with findings of moderate-to-severe white matter abnormalities from MRI obtained at 
term equivalent age significantly enhances the predictive specificity to 100% for the 
diagnosis of cerebral palsy in extremely preterm infants at early childhood (160). 
The aim of this last paragraph is finally not to provide 1:1 data comparison between 
the different functional and imaging assessment tools. This is anyway not possible 
because only the information concerning the aEEG summary abnormality score and 
contemporary cUS relates to the same infant population, while data concerning 
conventional EEG, MRI, and general movements have been obtained from separate 
cohorts. More important than an academically interesting comparison between the 
different assessments, is the fact that this information, complementary with neonatal 
and psychosocial factors, could help to improve early identification of preterm infants 
at higher risk for adverse outcome. 
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6. Conclusion and future directions 
Very preterm infants represent a growing patient population at significant risk for 
cerebral injury and neurodevelopmental impairments. Based on recent and 
representative prospective Swiss database, this thesis demonstrates that: 1) 
although more than a third of extreme preterm infants still suffer from moderate or 
severe ND, the rate of survival without major neurologic sequelae has increased 
significantly over the last decade, while the mortality rate decreased in Switzerland; 
2) outcome at two years of age in children surviving the neonatal period is best 
predicted by neonatal morbidities, among them major brain lesions; and 3) late 
outcome of young adults formerly born preterm with an extremely low birth weight is 
on overall satisfactory. The need for improved neuromonitoring, treatment, and 
prevention of brain lesion in the NICU is therefore high. By the current state of 
scientific knowledge, aEEG should become part of the daily care in every Swiss 
NICU as continuous neuromonitoring tool for critically ill newborn infants. This thesis 
demonstrates that aEEG is a valuable neurophysiologic diagnostic tool for the 
continuous bedside monitoring of brain function that may help clinicians in the early 
recognition of preterm patients at particular high risk for neurologic damage. In 
preterm infants compared to GA-matched controls, aEEG characteristics of severe 
brain lesion are amplitude suppression, absent cyclic activity, and higher likelihood of 
seizure activity. These findings should prompt at least an immediate cUS scan for 
further evaluation of brain injury. As neuroprotective studies are being conducted to 
improve long-term outcome in preterm infants, aEEG could play a critical role 
providing neurophysiological markers that would help to guide interventional 
strategies and to help parental counselling. In fact, the analysis of bedside aEEG 
early after birth may improve the identification of preterm infants at particular risk for 
adverse outcome, suppressed background and absent cycling activity on aEEG 
providing better predictive values than seizure occurrence. Some clinical conditions, 
the administration of certain medications, and artefactual features may, however, 
alter relevantly the aEEG tracing and confound its interpretation. On the other hand, 
preterm outcome can also be affected by non-cerebral morbidities (i.e. 
bronchopulmonary dysplasia) which cannot be primarily detected by aEEG 
monitoring. Therefore, the combination of aEEG tracing information with clinical and 
neuroimaging findings should be the aim of further research studies. In addition, and 
probably more importantly, longer follow-up protocols should be used in order to 
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assess the long-term prognostic relevance of early aEEG in preterm infants. The 
focus of further research needs to be put also on a relevant potential application of 
aEEG in the preterm population that may be of future clinical utility. In fact, beneath 
the possible role of aEEG for the early selection of patients at particular high risk of 
neurological complications and for possible neuroprotective intervention, continuous 
monitoring of the cerebral activity could support neurodevelopmental oriented care 
with particular attention on the premature signs of the patient’s sleep-wake cycling 
and tracing changes in response to sensorial stimuli. 
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